⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL3227329 | 0.75 | — | — | |
| SCHEMBL1191040 | 0.72 | — | — | |
| SCHEMBL31376856 | 0.72 | — | — | |
| SCHEMBL5821161 | 0.72 | — | — | |
| SCHEMBL16741 | 0.72 | — | — | |
| SCHEMBL8626057 | 0.72 | — | — | |
| SCHEMBL3888809 | 0.72 | — | — | |
| SCHEMBL33837 | 0.72 | — | — | |
| SCHEMBL4646 | 0.72 | — | — | |
| SCHEMBL3667891 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2048 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4349987-A1 | ANTISENSE NUCLEIC ACID | Sumitomo Pharma Co., Ltd. (JP) | 2024-04-10 | — | — | EP | claimed |
| CN-117750978-A | Synthetic peptide shuttle bioconjugates for intracellular cargo delivery | 费尔丹生物公司 | 2024-03-22 | — | — | CN | claimed |
| WO-2023198496-A1 | METHOD AND DEVICE FOR DETERMINING THE VITAMIN STATUS | Technische Universität München (DE) | 2023-10-19 | — | — | WO | claimed |
| EP-4261542-A1 | METHOD AND DEVICE FOR DETERMINING THE VITAMIN STATUS | Technische Universität München (DE) | 2023-10-18 | — | — | EP | claimed |
| WO-2018165132-A1 | POLYPHOSPHATES AS INHIBITORS OF CALCIUM CRYSTALLIZATION | UNIVERSITY OF HOUSTON SYSTEM (US) | 2018-09-13 | — | — | WO | claimed |
| US-20170198291-A1 | COMPOSITION FOR TREATING CANCER ASSOCIATED WITH HPV INFECTION | EnhancedBio Inc. (KR) | 2017-07-13 | — | — | US | claimed |
| US-20150299711-A1 | COMPOSITION FOR TREATING CANCER ASSOCIATED WITH HPV INFECTION | EnhancedBio Inc. (KR) | 2015-10-22 | — | — | US | claimed |
| EP-2881123-A1 | COMPOSITION FOR TREATING CANCER ASSOCIATED WITH HPV INFECTION | Abion Inc. (KR) | 2015-06-10 | — | — | EP | claimed |
| US-8946244-B2 | 2′-fluoro-6′methylene carbocyclic nucleosides and methods of treating viral infections | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2015-02-03 | — | — | US | claimed |
| US-8492362-B1 | 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-varicella zoster virus agents and methods of use | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2013-07-23 | — | — | US | claimed |
| US-5852188-A | Oligonucleotides having chiral phosphorus linkages | ISIS PHARMACEUTICALS, INC. (US) | 1998-12-22 | — | — | US | claimed |
| WO-1998056905-A1 | OLIGONUCLEOTIDE DERIVATIVES | NOVARTIS AG (CH) | 1998-12-17 | — | — | WO | claimed |
| WO-1997046569-A2 | 2'-SUBSTITUTED NUCLEOSIDES AND OLIGONUCLEOTIDE DERIVATIVES | NOVARTIS AG (CH) | 1997-12-11 | — | — | WO | claimed |
| EP-0655088-A1 | OLIGONUCLEOTIDES HAVING CHIRAL PHOSPHORUS LINKAGES | ISIS PHARMACEUTICALS, INC. (US) | 1995-05-31 | — | — | EP | claimed |
| WO-1993008296-A1 | OLIGONUCLEOTIDES HAVING CHIRAL PHOSPHORUS LINKAGES | ISIS PHARMACEUTICALS, INC. (US) | 1993-04-29 | — | — | WO | claimed |
| US-5079169-A | Method for optically manipulating polymer filaments | THE REGENTS OF THE STANFORD LELAND JUNIOR UNIVERSITY (US) | 1992-01-07 | — | — | US | claimed |
| EP-0099553-B1 | CEPHEM COMPOUNDS, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-27 | — | — | EP | claimed |
| US-4654422-A | Cephem intermediates | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-03-31 | — | — | US | claimed |
| US-4563449-A | BACTERICIDAL ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-01-07 | — | — | US | claimed |
| EP-0099553-A2 | Cephem compounds, process and intermediates for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-02-01 | — | — | EP | claimed |